drugset / Trial / NCT07662525
Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective, single-arm, open-lable, single-center study and we aimed to determine whether atorvastatin combined with N-acetyl-L-cysteine (NAC) plus romiplostim could induce sustained response off-treatment (SRoT) in adult patients with ITP following CS failure.
Timeline
- Start
- 2026-06-01
- Primary completion
- 2027-12-30
- Completion
- 2028-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 20 mg | — |
| Subject | N-acetylcysteine | Small molecule | 400 mg | — |
| Subject | Romiplostim | Peptide | 3 ug/kg | — |